WORK Medical Technology Group LTD Ordinary Shares Cash Flow Conversion Efficiency
WORK Medical Technology Group LTD Ordinary Shares cash flow conversion efficiency. Based on the latest financial reports, WORK Medical Technology Group LTD Ordinary Shares (WOK) has a cash flow conversion efficiency ratio of 0.427x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($9.04 Million) by net assets ($21.17 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of WORK Medical Technology Group LTD Ordinary Shares (2020–2025)
Cash flow conversion efficiency of WORK Medical Technology Group LTD Ordinary Shares from 2020 to 2025. This chart illustrates how WORK Medical Technology Group LTD Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest WORK Medical Technology Group LTD Ordina stock price today for real-time trading data and today's change.
WORK Medical Technology Group LTD Ordinary Shares Cash Flow Conversion Ratio Explained
WORK Medical Technology Group LTD Ordinary Shares cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
WORK Medical Technology Group LTD Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of WORK Medical Technology Group LTD Ordinary Shares ranked by their cash flow conversion efficiency. Also see WORK Medical Technology Group LTD Ordina (WOK) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Novra Technologies Inc
V:NVI
|
-0.231x |
|
Oragenics Inc
NYSE MKT:OGEN
|
-0.356x |
|
GECI International SA
PA:ALGEC
|
-0.181x |
|
Iveda Solutions Inc
NASDAQ:IVDA
|
-0.053x |
|
Montero Mining and Exploration Ltd
V:MON
|
-0.134x |
|
Performance One AG
F:PO1
|
N/A |
|
Roadman Investments Corp
V:LITT
|
-0.065x |
|
Neurizer Ltd
AU:NRZ
|
-0.015x |
Annual Cash Flow Conversion Efficiency for WORK Medical Technology Group LTD Ordinary Shares (2020–2025)
The table below shows the annual cash flow conversion efficiency of WORK Medical Technology Group LTD Ordinary Shares from 2020 to 2025. Review WORK Medical Technology Group LTD Ordina free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $21.17 Million | $6.24 Million | 0.295x | +312.73% |
| 2024-09-30 | $16.07 Million | $-2.23 Million | -0.139x | -168.93% |
| 2023-09-30 | $10.99 Million | $2.21 Million | 0.201x | +199.64% |
| 2022-09-30 | $11.19 Million | $-2.26 Million | -0.202x | +67.96% |
| 2021-09-30 | $11.39 Million | $-7.18 Million | -0.630x | -113.73% |
| 2020-09-30 | $5.93 Million | $27.20 Million | 4.589x | -- |
About WORK Medical Technology Group LTD Ordinary Shares
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anes… Read more